Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2024 Q3 | Sep 30, 2024 | ITUS Capital | - | - | ABB.NS, AUROPHARMA.NS, BAJAJ-AUTO.NS, BHARATFORG.NS, BLUESTARCO.NS, DRREDDY.NS, EICHERMOT.NS, GAIL.NS, HAVELLS.NS, ICICIGI.NS, IEX.NS, IPCALAB.NS, ITC.NS, MARICO.NS, MARUTI.NS, NTPC.NS, PETRONET.NS, POWERGRID.NS, RELIANCE.NS, SBILIFE.NS | Autos, earnings, India, large cap, liquidity, Pharmaceuticals, Power, Rural | Strong earnings growth driven by domestic fundamentals with portfolio companies showing 30.6% EPS growth year-over-year. Structural improvement in RoEs for top 500 companies in India over the last 4 years has resulted in strong market performance. Focus on companies where earnings growth is accompanied by RoE expansion. | View | |
| 2025 Q1 | Mar 31, 2025 | ITUS Capital | - | - | ABB.NS, AUROPHARMA.NS, BAJAJ-AUTO.NS, DRREDDY.NS, EICHERMOT.NS, GILLETTE.NS, HAVELLS.NS, HDFCAMC.NS, HDFCBANK.NS, HINDCOPPER.NS, ICICIBANK.NS, ICICIGI.NS, ITC.NS, MARICO.NS, PBFINTECH.NS, PIRAMALP.NS, TITAN.NS, TVSMOTOR.NS, ULTRACEMCO.NS, VEDL.NS | banks, consumer, Government Spending, India, large cap, Pharmaceuticals, tariffs, valuation | Portfolio is overweight banks with focus on market leaders like ICICI Bank and HDFC Bank. Manager expects bottoms-up outlook on lending growth and views banks as offering better risk-reward at current valuations. | View | |
| 2024 Q4 | Dec 31, 2024 | ITUS Capital | - | - | AMBUJACEM.NS, AUROPHARMA.NS, BAJAJ-AUTO.NS, DRREDDY.NS, EICHERMOT.NS, GAIL.NS, HAVELLS.NS, HDFCAMC.NS, HDFCBANK.NS, ICICIBANK.NS, IEX.NS, ITC.NS, KEI.NS, LT.NS, MARICO.NS, PBFINTECH.NS, PIRAMALP.NS, POWERGRID.NS, RELIANCE.NS, TVSMOTOR.NS | Capex, Copper, Domestic Flows, healthcare, India, infrastructure, technology, Two Wheelers | Healthcare continues to be the largest exposure across portfolios with strong growth outlook benefiting from low-cost manufacturing and lower price erosion in US pharma. The manager expects CY25 to be a strong growth sector for pharma which is reflected across portfolio positioning. | ICICIGI.NS |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| No pitches found. | |||||||||
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||